<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD010743-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD010743-sec-0036"></div> <div class="table" id="CD010743-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Xylitol toothpaste versus control toothpaste for preventing dental caries</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Xylitol toothpaste compared with control toothpaste for preventing dental caries</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> children with permanent teeth </p> <p><b>Settings:</b> schools </p> <p><b>Intervention:</b> fluoride toothpaste containing 10% xylitol </p> <p><b>Comparison:</b> fluoride toothpaste </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Control</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Xylitol</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Caries: increment (DFS) prevented fraction (PF) at 2.5 to 3 years followâup</b> </p> <p><b>(higher DFS score indicates worse caries)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The (weighted) mean caries increment for control groups was<br><b>2.1</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean caries increment in the xylitol groups was</p> <p><b>0.28 lower</b> </p> <p>(0.42 to 0.14 lower)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>PFÂ¹ = <b>0.13</b> (0.08 to 0.18) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4216<br> (2 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>low</b>Â² </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>The PF of 0.13 means that there was a 13% reduction in caries in the xylitol group</b> </p> <p>There is no compelling evidence, from other comparisons in this systematic review, to support the use of xylitol products. The body of evidence for all other comparisons and caries outcomes is rated as being low to very low quality. This is because they are single studies with imprecision mostly due to very small sample sizes, and most of which have a high risk of bias </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Both studies reported that there were no adverse effects in either the xylitol or control group </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> Confidence interval; <b>DFS:</b> decayed filled surfaces; <b>PF:</b> prevented fraction </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p>Â¹ The prevented fraction (PF) is calculated as follows: the mean increment in the controls minus the mean increment in the treated group divided by the mean increment in the controls </p> <p>Â² Downgraded due to high risk of bias in the included studies (due to high attrition) and both studies were conducted by the same authors in the same population </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
